Related Experiment Video
Updated: Jul 18, 2026
07:26
Cell-based Calcium Assay for Medium to High Throughput Screening of TRP Channel Functions using FlexStation 3
Published on: August 17, 2011
[Be careful in using flecainide by hemodialyzed patients]
Richard Montagnac1, Eric Schoen, Camélia-Pop Aliouche
1Service de Néphrologie-Hémodialyse, Centre Hospitalier de Troyes, 10003 Troyes cedex, France. richard.montagnac@ch-troyes.fr
Nephrologie & Therapeutique
|December 23, 2006
Summary
Flecainide treats cardiac arrhythmias in hemodialysis patients but shows variable responses due to genetic metabolism. Careful dosing and monitoring are crucial to prevent serious side effects.
Area of Science:
- Pharmacology
- Nephrology
- Cardiology
Background:
- Cardiac arrhythmias are common in patients undergoing hemodialysis.
- Flecainide is an antiarrhythmic drug often prescribed for these patients.
- Interindividual variability in flecainide's dose-plasma concentration relationship is significant.
Observation:
- Flecainide metabolism is genetically controlled and polymorphic.
- Renal clearance alone is insufficient for accurate flecainide dose adjustment.
- Hepatic insufficiency and concurrent medications further complicate dosing in hemodialysis patients.
Findings:
- Polymorphic metabolism leads to unpredictable flecainide plasma concentrations.
- Standard dose adjustments based solely on renal function are inadequate.
- Complex factors necessitate cautious flecainide initiation and monitoring.
Implications:
- Close monitoring of flecainide plasma concentrations is essential in hemodialysis patients.
- Physicians must exercise caution when prescribing flecainide due to potential adverse events.
- Individualized therapeutic drug monitoring is critical to optimize flecainide therapy and avoid toxicity.
Related Concept Videos
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:25Hemodialysis III: Nursing Management
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
01:24Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...